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ABSTRACT 
 
Introduction: Currently, routine screening for HIV, hepatitis B and C and syphilis is done 
in most blood banks in the world. Methods: We conducted a prospective descriptive 
study at the National Blood Transfusion Center (CNTS) Antananarivo for a period of 7 
months from January to July 2014, which aims to assess the socio-clinical factors 
accompanying ineligibility of blood products and to determine the seroprevalence of HIV, 
hepatitis B, C and syphilis of the blood donors who have spent at CNTS HU - JRA 
Antananarivo during this period. All donors who have abnormal results of microbiological 
examinations were included. The parameters used and studied were age, sex, marital 
status, blood and results microbiological examinations for HIV, hepatitis B, C, and syphilis. 
The prevalence of blood donors who presented a serological abnormality is 3.95% with a 
predominance of donors with hepatitis B (72.93%) followed by syphilis (18.29%) of the 
hepatitis C (6.95%) and HIV (1.80%) and a predominance of young people. Conclusion: At 
the CNTS Antananarivo, the HBV is the main definitive reason for exclusion of these 
donors. This high prevalence is a real public health problem for the country's health 
authorities. The search for maximum safety in blood transfusion through firstly a better 
selection of blood donors by implementing a policy of strong loyalty and other early 
diagnosis of major diseases transmissible by blood and likely to infect the recipient. 
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INTRODUCTION 
Blood safety is a public health problem extremely concern for 
health authorities. And, many efforts have been made in the 
development of measures to reduce the risk of transmission 
of infectious agents by blood transfusion[1]. At present, 
screening the virus of human immunodeficiency (HIV), 
hepatitis B and C (HBV and HCV) and the pale of syphilis 
Treponema is performed in most blood banks in the world [2]. 
In Madagascar as in most African countries, the main problems 
in blood transfusion are insufficient in blood bags [3]. This study 
aims to establish epidemiological data on seroprevalence of 
HIV, HBV and HCV and syphilis to the CNTS (National Blood 
Transfusion Center) of the HU - JRA (University Joseph 
Ravoahangy Andrianavalona hospital) Antananarivo our work 
is the study of data collected from blood donors during blood 
transfusion carried out at the National center of Transfusion 
of blood of the Joseph Ravoahangy Andrianavalona (HU-JRA) 
of Antananarivo University Hospital. 
MATERIALS & METHODS 
Study design: It is a prospective and descriptive study. 
Study location:  Present study was carried out to the CNTS HU 
JRA Antananarivo. 
Time frame: For a period of seven months from January to July 
2014. 
Ethical approval: The study was approved by the donors and 
the responsibility at the CNTS, no information revealing 
donors identity was present in this study. 
Sample size and inclusion criteria: Our mode of sampling was 
of exhaustive type and we have included blood donors who 
donated to the CNTS of the HU - JRA Antananarivo during this 
period. All blood donors that microbiological test results are 
abnormal were included. 
Methods: In the present study used a technique using the test 
of rapid diagnosis (TDR). For the virus of hepatitis B (HBV), TDR 
type Viruchek HBs Ag, for the virus of hepatitis C (HCV), TDR 
Anti - HCV Dipstich, for HIV, the TDR which is to detect the 
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antibodies to HIV 1 and HIV 2 by Determine® (Inverness 
Medical Japan) is used, and for the syphilis, TDR of the 
agglutination latex type RPR test kits BIO-RAD, France. 
Confirmation of the test with the TPHA test is not performed 
at the Center.  
Selected and studied variables were age, gender, and the 
results of the search for markers direct or indirect of the virus 
of hepatitis B, hepatitis C, HIV and syphilis. Blood group donor 
privacy has been respected, as the anonymity of the donation 
requires it.  
Statistical analysis: The analysis and management of data 
were made with the software epi info 6.04 with a level of 
significance of 0.05. For the comparison of the percentages, 
the Fisher χ2 test was used. 
RESULTS 
During these 7 months, we have 9807 blood donors after 
medical selection we found anomalies microbiological at 388 
donors or 3.95% of which 330 are male (M) and 58 (F) female, 
sex-ratio = 5.68, and is divided according to grouping ABO RH 
161 (O +), 122 (B +), 74 (A +), 31 (+ AB) and one from Group A-
. These 388 donors with microbiological abnormalities are 
divided as follows: hepatitis B was detected in 283 patients 
(72,93%), hepatitis C in 27 patients (6.95%), HIV in 7 patients 
(1.80%), and syphilis in 71 patients (18,29%) in all of the 
positive cases. We tracked 6 co-infections including 5 hepatitis 
B - syphilis and a hepatitis B - HIV cases (1.54%). 
 Compared to total donors, hepatitis B seroprevalence was 
2.88%, hepatitis C of 0.27%, 0.07% HIV and syphilis by 0.78% 
to 0.06% co-infection. 
Table 1. Distribution of positivity by age 
Age (year) HBV (n*) HCV (n) HIV(n) SYPHILIS(n) 
18- 20 11 0 0 4 
20- 25 69 1 1 13 
25- 30 60 1 2 15 
30- 35 48 4 2 13 
35- 40 41 2 2 8 
40- 45 26 4 0 9 
45 28 12 0 9 
TOTAL 283 27 7 71 
n* : number 
Table 2. Distribution of serologic results according to the 
family situation 
 Positive n (%) Négative n (%) 
Single 98    (25.26) 22   (5.67) 
Married 185  (47.68) 82   (21.13) 
Table 3. Distribution of gender anomalies 
Parameters Male Female P value  
HBV Positive  247 (63.7) 36 (9.3) 0.09 
Negative  83 (21.4) 21  (5.4) 
HCV Positive  20 (5.2) 6  (1.6) 0.33 
Negative  310 (79.9) 51 (13.1) 
HIV Positive  6 (1.8) 1 (0.3) 0.74 
Negative  323 (83.3) 56 (14.4) 
Syphilis Positive  59 (15.2) 17 (4.4) 0.05 
Negative  271 (69.9) 40 (10.3) 
DISCUSSION  
For the poor countries of Africa such as Madagascar to 
majority or resources are limited, and the very fragile 
healthcare system availability and safety of blood and blood 
products for transfusions continue to be of concern, especially 
with the existence of the prevalence in these populations of 
the infectious markers such as HIV/AIDS and other Infections 
such as hepatitis B hepatitis C and syphilis. Blood transfusion 
is a crucial component of modern health care. Ensure a 
suitable blood safety turns out being of undeniable necessity 
for her health the recipient especially in the circumstances or 
the prevalence of infectious agents transmissible by blood are 
high. This under defined a good knowledge of the 
epidemiology of these various markers followed their routine 
testing on all units of blood collected. Indeed, labile blood 
products must all be safe, effective clinical and in line with the 
desired quality. For this good transfusion policy relying on 
rigorous strategies must be put in place. This policy involves 
not only the creation of a national blood transfusion well-
organized structure that coordinates national collections in 
from blood donors in populations at low risk; but as the 
routine screening on all blood donations (including: research 
infectious agents transmissible by transfusion, blood 
grouping, compatibility tests and appropriate clinical use of 
blood). Finally a good blood policy requires the development 
of a system of effective quality assurance which is able to 
guarantee traceability, from the recruitment and selection of 
donors until the distribution of labile blood products. This 
traceability takes into account not only the transfusion 
activities but also control and the proper use of the reagents 
and consumables used in routine. The quality policy must also 
be adapted structure, the needs and the possibilities of blood 
transfusion center as well as to the needs of hospitals and 
patients served [1]. 
1. Distribution of donors according to factors socio - clinical  
Distribution of donors by gender is variable depending on the 
country. There was a male predominance in Madagascar, as in 
other countries like Burkina Faso, Tanzania, Eritrea, the 
Greece, the India of the North [2-6]. In other countries like 
Britain, they present a female [7]. This masculine trend can be 
explained by a typical African belief that men are healthier and 
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more robust than women [8-9]. Factors obstetrical gynecologist, 
as menstrual cycles, pregnancy, breastfeeding can also 
influence this trend. The average age of donors is 35 years 
(Table 1), identical with other African countries like Tanzania, 
Ethiopia, Ghana, Albania including the average age of donors 
respectively 20-39 years, 35 years, 26-35 years old, is 40.1 
years [4,10-13]. This trend can be explained by the fact that 
awareness for blood donors was made especially for this age 
group or has been effective on this age group [10].  
It is mainly young people (20-29 years) sexually more active 
and potentially more exposed to infections which give their 
blood. Despite awareness campaigns on sexually transmitted 
infections among young people, it is not less that many of 
them by their socio-economic vulnerability continue to adopt 
high-risk behaviors. We also see that married donors (Table 2) 
are the most affected by microbiological anomalies. This result 
is significant with a p-value = 0.01. This result opens another 
avenue of study about the sexual behavior of married men. 
What is inconsistent with our usual belief that said that 
married men are loyal while the results here showed 
otherwise. National transfusion policy follows the 
recommendations of the WHO and is based on the 
recruitment of non-remunerated voluntary blood donors, 
mainly young people, of masculine gender that often 
represent the majority of regular donors. This blood donor 
recruitment policy advocated by WHO is a problem in 
Madagascar because obviously, it does not yet meet the 
strong demand for blood bags. 
2. Distribution according to the results of laboratory tests  
On 9807 donors included in the study, 3.95% (n = 388) had at 
least a positive serology among 4 sought pathogens. HIV 
seroprevalence is 0.07% with an average age of 29 years and a 
sex ratio of 5.68 without significant gender difference (p > 
0.05). Seroprevalence of HBV is 2.88%, with an average age of 
33 years and a sex ratio of 6.86 (p > 0.05). The seroprevalence 
of HCV is 0.27% with an average age of 40 years and a sex ratio 
of 3.33 without significant difference between the male and 
female gender (p>; 0.05). Seroprevalence of T. Pallidum is 
0.78%, with an average age of 34 years and a sex ratio of 3.47 
(p >0.05). The predominance of the male gender is not 
significant on the seroprevalence of these last 2 infections. We 
found 6 co-infections including 5 hepatitis B - syphilis and a 
hepatitis B - HIV cases. Seroprevalence for co-infection is 
0.06%. Our results are different to those of the study 
conducted in 1993 and in 2010 Madagascar volunteer donors 
in which he had no cases of HIV positivity [14]. Seroprevalence 
of HIV among blood donors had a tendency to increase over 
the years. However, the prevalence of HIV among donors is 
similar to some countries, such as Eritrea[15] and the India of 
the North[6] where the seroprevalence is 0.11 %, 0.24 % 
respectively, but it is high compared to that of some African 
countries, 2.21% for Burkina – Faso[3], 2% for Tanzania[4,10]. 
Our results are similar to those of a study conducted in Malawi 
where the lower prevalence has been observed among the age 
group of 15-19 years’ blood donors and students[11].  The low 
prevalence of HIV found in older donors of less than 25 years 
is the result of the awareness campaigns on HIV/AIDS started 
a few years back in the direction of these populations. Analysis 
of rate by gender indicates that male blood donors are more 
affected than female donors[16]. For HBV, seroprevalence 
tended to diminish over the years. This may be due to the 
awareness of the Malagasy population for hepatitis B 
vaccination. The prevalence of HBV that we found in our study 
is so low compared to other African countries. She is 14.96% 
for Burkina Faso [3], 7.2 percent for Tanzania[4], however it is 
2.47% for Eritrea2 and 0.42% for Greece [5]. Despite this, HBV 
is still the main reason for the definitive exclusion of these 
volunteer donors of blood to the CNTS. This tendency to 
reduction of seroprevalence over the years in volunteer 
donors are also noted for T. pallidum [14]. This may be due to 
systematic screening of this infection in pregnant women. 
Thus, those who have a woman with a positive serology for 
syphilis during the prenatal consultation come more to give 
blood. These men are so self-screening [10]. The majority of the 
incidental infections were found among men (63.66%), which 
constitutes the bulk of donor population in Madagascar as in 
Africa sub-Saharan 16-19. Indeed, high prevalence of markers of 
hepatitis B and C were found respectively in blood donors in 
rural areas and in urban areas according to the literature [10]. 
There are also donors of blood from the provinces, 
explanations would come from the way of life of these rural 
populations (ethnic tattoos, lifestyle community etc.)[19]. 
Mobile collections from donors are young majority and the 
HBV shrinks between 20 and 30 years where a high prevalence 
of this marker[20].  However, the high frequency of 
seroconversion to HBV among our donors imply that sexual 
transmission takes place in adults. In sub-Saharan Africa, the 
prevalences of the Ag HBs are generally high. Indeed, the Ag 
HBs is the main marker research for the diagnosis of HBV in 
blood donors. It is urgent to associate other markers of 
infection to add to the screening of the Ag HBs. Unlike the 
studies of Tsega et al.[21], and Ryder et al. [22] who asked the 
question of the need screening of the Ag HBs in donors of 
blood in sub-Saharan Africa, this screening is more than 
necessary to do the high prevalences. However, the anti-HCV 
seroprevalences were higher than those described in other 
West African countries [23-25]. Anti-HCV antibodies have been 
found mainly among donors over 30 years. The 
seroprevalence according to age shows that the under 20 age 
group is least affected (0%), and most affected is that of more 
than 45 years (50%). The prevalence of HCV in blood to the 
Antananarivo donors are higher than the values found in the 
U.S. to 0.07% and lower than those found in Europe (0.6%) [26-
27]. This prevalence is substantially lower than the reported 
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prevalence of 12.3% Nigeria[28] blood donors. Indeed, in 
Antananarivo, intravenous drug use is still not widespread, the 
most likely explanation lies in use in rural areas of sharp 
objects that may be potentially infectious in circumcisions, 
ethnic tattoos, scarification, and recently the piercing of big 
cities like Antananarivo. youth the seroprevalence of HCV was 
a trend slightly increased over the years. A rise in the 
prevalence has been found from a study done in 2003 until 
2009, because the selection of donors grew especially after 
the passage of the Red Cross of Belgium in 2007 [29]. The 
seroprevalence of HCV is high compared to other countries 
like Ethiopia, the Mexico where she is of 0.7% and 0.79% 
respectively [10]. The seroprevalence of syphilis in this study is 
lower than that found in donors of blood in Tanzania [30], also 
lower than that observed in Nigeria [31], 12.8% Ethiopia and 
Tanzania 12.7%[32]. The difference between these very high 
prevalences and ours could not be elucidated, but could be 
attributed to geographical variations that probably affect the 
prevalence of syphilis [33]. This persistence of infectious 
markers in donors of blood to the Antananarivo population 
could justify an also high incidence of these infectious agents. 
Seroprevalence of T. pallidum was lower compared to that of 
Burkina Faso and Tanzania with 1.5 percent, 3.96 percent 
respectively as against it is 0,32% to Eritrea [10].  
In view of the high frequencies of the HBV co-infection with 
one or several infectious diseases markers were present with 
HBV but with a rather high prevalence. The transmission of 
HCV is related to the direct contact with blood, while no 
association between HCV and HBV infection were found. 
However, the prevalence of co-infection between HBV, HIV, 
and syphilis was not similar to the prevalences of individual 
markers that explains the channels of infections are probably 
not the same. The predominance of the male gender (table III) 
in our results was not significant nor for HIV, HBV, HCV or T. 
pallidum, which is not the case for Ethiopia [33] where a female 
has been reported, the male for Burkina Faso[3] and for the 
North, Ghana India, Brazil the predominance of the male is 
encountered in the four infections[10]. These results show the 
heterogeneity of the tendency of these infectious agents in 
volunteer donors. The sensitivity of the kits used for screening 
for HIV in the CNTS, (100%) [34] and HBV (> 99.7%) correspond 
to the recommendation of the WHO for the donation of blood 
except for HCV which is between 97-99%. These tests allow to 
minimize the risk of transmission. Despite efforts to improve 
blood safety. There is always a residual risk of transmission of 
these agents infections during the window period [35], hence 
the need for another prospective study for the determination 
of the residual risk. 
CONCLUSION  
Research of infectious agents transmissible through blood to 
blood donors varies according to the epidemiological context, 
but HIV, HBV, and HCV t. pallidum is searched systematically 
in all blood donors as recommended by WHO. At the CNTS 
Antananarivo, the HBV is the main definitive reason for 
exclusion of these donors. This high prevalence is a real public 
health problem for the country's health authorities. The 
search for maximum safety in blood transfusion through firstly 
a better selection of blood donors by implementing a policy of 
strong loyalty and other early diagnosis of major diseases 
transmissible by blood and likely to infect the recipient. 
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